GRP
DFTX

Global Retirement Partners’s Definium Therapeutics DFTX Stock Holding History

Global Retirement Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1K Buy
+66
New +$1.63K ﹤0.01% 3851
2025
Q4 		$7.58K Buy
566
+66
+13% +$817 ﹤0.01% 3269
2025
Q3 		$5.89K Buy
+500
New +$4.66K ﹤0.01% 2912

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Global Retirement Partners's DFTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 66 shares worth $3.1K. The stake represents ﹤0.01% of the portfolio and ranks #3851 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in DFTX as recently as Q4 2025.

Global Retirement Partners first reported a position in DFTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.58K in Q4 2025. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Global Retirement Partners held 66 shares of Definium Therapeutics worth $3.1K as of Q2 2026.
  • Definium Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3851 holding.
  • Global Retirement Partners first reported a position in Definium Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Global Retirement Partners's Definium Therapeutics position peaked at $7.58K in Q4 2025.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.